The VP of Clinical Biostatistics will provide strategic leadership and operational oversight for the design, analysis, and reporting of clinical trials. This role involves building and leading a high-performing team while collaborating with cross-functional stakeholders to drive clinical programs and regulatory submissions.
The director will act as a strategic partner to the Asset Entrepreneur, overseeing end-to-end program execution and cross-functional operations. They are responsible for translating complex scientific and operational data into clear insights for the C-suite and Board to drive decision-making.
The Clinical Development Director will own the core clinical development plan and design the first-in-human strategy for novel therapeutic assets. They will also build and manage KOL and site networks while shaping translational and biomarker strategies to ensure successful proof-of-mechanism readouts.
The Sr. Clinical Development Director will collaborate with the VP of clinical development on asset strategy and lead key study activities. This role involves designing new clinical protocols, analyzing data, and communicating findings to stakeholders.
